Noret 28 0.03 mg+0.15 mg+75 mg (Tablet)

Indications

• Inhibit Ovulation
• Inhibit sperm to enter into the uterus by condensing uterine mucus
• Inhibit fertilized egg to accept by uterus by protecting the growth of membrane inside the uterus
• Reduce the movement of sperm by minimizing normal movement of fallopian tube
• Suitable for women aged between 15-69 years (except smoker and who use tobacco regularly)
• Effective temporary contraceptive method
• Anemia due to excessive blood loss during menstruation
• Irregular menstruation cycle
• Breastfeeding mother (if child age is more than 6 months)

Composition

• Each White (Hormone) Tablet contains Ethinylestradiol USP 0.03 mg & Levonorgestrel USP 0.15 mg
• Each Brown color (Iron) tablet contains Ferrous Fumarate BP 75 mg

Pharmacology

• Combination oral contraceptives lower the risk of becoming pregnant primarily by suppressing ovulation
• Cervical mucus changes that inhibit sperm penetration
• Endometrial changes that reduce the likelihood of implantation
• Contains two hormones: Levonorgestrel and Ethinyl Estradiol

Dosage & Administration

• Start taking tablet from the first day of menstruation or within the first 5 days
• Take one tablet same time each day with food, preferably after dinner or before sleeping at night
• Start with one white tablet each day for 3 weeks, then one brown color tablet each day for 7 days
• If menstruation starts while taking brown color tablet, continue the medicine
• If not pregnant is confirmed, start from any day of menstruation and use condom during sexual intercourse for next 7 days if brown tablets not finished yet

Interaction

• Drugs or herbal products that induce certain enzymes, including CYP3A4 may decrease the effectiveness of COCs or increase breakthrough bleeding
• Recommend avoiding caffeine, dairy foods, phytic acid containing food while taking the drug

Contraindications

• Known hypersensitivity to any of the components of this product

Side Effects

• Common: Headache, nausea, mood changes including depression, vaginal infections, irregular vaginal bleeding, pain and discomfort
• Rare: liver tumors, jaundice, high blood pressure & gallbladder problem

Pregnancy & Lactation

• Contraindicated in pregnancy
• Discontinue if pregnancy occurs
• CHCs including this pill can reduce milk production in breastfeeding females

Precautions & Warnings

• Stops this pill if a thrombotic disorder occurs
• Discontinue if jaundice occurs
• Monitor blood pressure and stop if it rises significantly in women with well-controlled hypertension
• Monitor prediabetic and diabetic women
• Evaluate significant change in headaches and discontinue if indicated
• Evaluate irregular bleeding or amenorrhea

Use in Special Populations

• Safety and efficacy of this pill have been established in women of reproductive age
• Efficacy is expected to be the same in post-pubertal adolescents under the age of 18 years as for users 18 years and older

Overdose Effects

• No reports of serious illness effects from overdose
• Over dosage may cause withdrawal bleeding in females and nausea

Therapeutic Class

• Oral Contraceptive preparations

Storage Conditions

• Store below 30°C, protected from light & moisture
• Keep all medicines out of reach of children

Related Brands

• Femipil 0.03 mg+0.15 mg+75 mg (Tablet) - beximco-pharmaceuticals-ltd